Sponsor intelligence · INDUSTRY
Clinical trials sponsored by
AbbVie.
Real, source-linked trial activity for AbbVie: 10 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Aug 5, 2026. Source-linked, daily-refreshed.
PHASE2 4PHASE1 3N/A 2PHASE3 1
Newest AbbVie trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 2d ago | A Study to Assess Adverse Events, Change in Disease Activity and Optim | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 3d ago | Effectiveness of Upadacitinib and Biologics for the Achievement of Min | N/A | NOT_YET_RECRUITING | ↗ |
| 7d ago | A Study to Assess the Safety, Tolerability and How Single Ascending Do | Ph 1 | NOT_YET_RECRUITING | ↗ |
| 9d ago | A Study to Assess the Safety and Efficacy of AGN-151586 Injections for | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 10d ago | A Study to Evaluate Adverse Events and Change in Disease Activity With | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 24d ago | Study of Advanced Therapies for the Treatment of Adult Participants Wi | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 30d ago | A Study to Evaluate Adverse Events and Change in Disease Activity of M | N/A | NOT_YET_RECRUITING | ↗ |
| 35d ago | Study to Assess How Different Oral Formulations of Ubrogepant Move Thr | Ph 1 | NOT_YET_RECRUITING | ↗ |
| 38d ago | Study of AGN-151607-DP to Assess Adverse Events and Change in Disease | Ph 2 | RECRUITING | ↗ |
| 38d ago | A Study to Assess Safety, Tolerability, and How Single and Multiple In | Ph 1 | RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for AbbVie (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.